Clinical Trial Update: Efficacy and Safety of Ursodeoxycholic Acid (UDCA) Added to the DPP-4 Inhibitor in People With Type 2 Diabetes and Chronic Liver Diseases [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the efficacy and safety of adding ursodeoxycholic acid to a DPP-4 inhibitor in adults with type 2 diabetes and chronic liver d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• DPP-4 inhibitor
• Ursodeoxycholic acid (ursodeoxycholic acid)

Snippet

Sponsor: Kanazawa University | Conditions: Type 2 Diabetes Mellitus, Chronic Liver Disease | Phase 4 | Status: UNKNOWN